.jpg)
6 hours ago
1
Article content
Clinicians can now access full medication data and interaction checks in seconds
THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
SUBSCRIBE TO UNLOCK MORE ARTICLES
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
REGISTER / SIGN IN TO UNLOCK MORE ARTICLES
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account.
- Share your thoughts and join the conversation in the comments.
- Enjoy additional articles per month.
- Get email updates from your favourite authors.
THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account
- Share your thoughts and join the conversation in the comments
- Enjoy additional articles per month
- Get email updates from your favourite authors
Sign In or Create an Account
or
Article content
Article content
MONTREAL — Pathway today announced the launch of a fully integrated drug reference and drug-drug interaction checker within its AI-powered medical knowledge platform. Clinicians can now access comprehensive medication information for over 2,000 drugs and screen for interactions directly within the same interface they already use for clinical guidance.
Article content
Article content
Pathway’s drug reference is powered by a proprietary database that is uniquely structured to support AI-native use. It enables consistent, context-aware access to medication data across thousands of clinical scenarios. This foundation is further complemented by trusted sources like the American Hospital Formulary Service (AHFS), a gold-standard reference maintained by the American Society of Health-System Pharmacists (ASHP) and widely used by clinicians and institutions across the United States. Together, this combined data supports clinically relevant and responsible integration within the Pathway platform.
Article content
Article content
“Clinicians face constant time pressure and information overload,” said Dr. Louis Mullie, Chief Medical Officer at Pathway. “We built this to keep prescribing information within the flow of care. Medication errors affect over a million patients annually in the U.S., often due to incomplete information or workflow disruptions. By enabling instant access to full monographs and interaction guidance within the Pathway AI experience, we help clinicians make safer and faster decisions without disrupting their workflow.”
Article content
By signing up you consent to receive the above newsletter from Postmedia Network Inc.
Article content
Clinicians can now ask drug-related questions in plain language through Pathway AI, such as “What is the dose of pregabalin for postherpetic neuralgia?” or “What is the dose of bupropion for depression in a patient with liver cirrhosis?”, and receive clear, structured answers in seconds. Pathway’s new interaction checker also enables quick screening for potential conflicts between medications without needing to switch tools or interrupt patient care.
Article content
“At Mee Memorial, Pathway has become an essential part of how we deliver care,” said Dr. Noah Hawthorne, MPH, Chief Medical Officer at Mee Memorial Healthcare System. “More than half of our searches involve drug information. Pathway’s integrated medication database consistently delivers reliable, fast answers, whether for routine prescriptions or complex, patient-specific decisions.”
Article content
This achievement highlights Pathway’s continued leadership at the intersection of AI and clinical decision support. In 2024, the platform became the first generative AI tool in medicine to offer continuing medical education (CME) credit for every question asked, embedding ongoing education into everyday use. In March 2025, the company also introduced HIPAA-compliant access for Pathway Plus subscribers, supporting secure and compliant use of patient-specific information in AI queries. Earlier this month, Pathway’s proprietary “Deep” model achieved the highest score ever reported for any publicly available specialized medical AI.
Article content
About Pathway
Article content
Pathway is one of the most widely used AI-powered medical platforms, designed to support real-time clinical decision-making. It helps clinicians work more efficiently, reduce burnout, and stay current with evidence-based guidelines and literature. Combining advanced AI with proprietary data and structured medical knowledge, Pathway delivers fast, transparent answers to complex clinical questions. The platform is built for accuracy, safety, and ease of use, and is used by clinicians in over 10,000 care centers across the United States and internationally.
Article content
To learn more or try Pathway, visit www.pathway.md
Article content
Article content
Article content
Article content
Article content
Article content
Contacts
Article content
For media inquiries, contact [email protected]
Article content
Article content
English (US)